Global Oxygen and Aerosol Delivery Devices Market

Report ID : 1275 | Published : 2022-06-21 | Pages: | Format: PDF/EXCEL

The Global Oxygen and Aerosol Delivery Devices Market is estimated to reach over USD 69.32 billion by 2030, exhibiting a CAGR of 6.8% during the forecast period. 

As rescue therapy or long-term treatment, oxygen and aerosol delivery systems are used to treat respiratory and non-respiratory illnesses.  A chemical is delivered directly to the lungs for a systemic impact; this is the most sophisticated method of medication administration.  In the treatment of asthma and COPD, oxygen and aerosol delivery devices such as dry powder inhalers, metered-dose inhalers, and nebulizers are often used. These devices are also used to treat non-respiratory illnesses such as diabetes, analgesia, and Parkinson's disease. The rising prevalence of respiratory disorders such as COPD, asthma, and cystic fibrosis is anticipated to be a prime market driver. Increased emphasis by manufacturers on producing portable inhalation devices for rescue equipment treatment during a sudden asthmatic attack, demand for short-term, effective asthma and COPD medication, and government initiatives to raise awareness of COPD and asthma symptoms, all of which are driving the oxygen and aerosol delivery market forward.

Technological advancements in inhaler devices, patient adoption of oxygen and aerosol delivery devices, urbanization, and pollution levels, as well as a rise in the number of R&D initiatives aimed at developing optimal inhalation therapy are all factors that contribute to market growth. However, issues and adverse effects connected with drug inhalation, as well as the high cost of nebulized, are expected to impede the market.

Market Segmentation:

The Oxygen and Aerosol Delivery Devices market is segregated on the basis of Product and application. By Product, the market is segmented as Oxygen Masks, Nasal Cannulas/ Oxygen catheters, Oxygen Connecting Tube, Venturi Masks, Non-rebreather Masks, Reusable Nebuliser, Disposable Nebuliser and Other Oxygen Delivery Devices. By application, the market is segmented into COPD, Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia and Other Diseases.

Based on Product, the oxygen masks segment is accounted as a major contributor in the Oxygen and Aerosol Delivery Devices market.

The oxygen masks category is predicted to grow at a constant rate as a result of these masks being an essential part of the O2 delivery system, resulting in increased consumption and so serving as a key contributing factor to the oxygen and aerosol delivery device market growth in the future. Furthermore, these devices enable correct O2 concentration delivery, continuous flow and pressure, and patient comfort, which is expected to drive segment demand.

The COPD segment witnessed growth at a rapid rate

COPD accounted for most of the oxygen and aerosol delivery device market. Sleep apnea, asthma, and viral diseases came in second and third, respectively. The rising prevalence of smoking and environmental factors can be blamed for COPD's significant market share. This segment, followed by asthma, is predicted to expand the fastest in the market. Furthermore, the latest COVID-19 outbreak will have an impact on COPD sufferers. While they are not at an increased risk of developing the disease, it can have severe consequences for them. As a result, demand for respiratory care devices is likely to rise during the forecast period due to the high incidence of COPD and the rising number of deaths caused by COPD.

The Asia Pacific Oxygen and Aerosol Delivery Devices market holds a significant revenue share in the region.

The Asia Pacific is anticipated to evolve significantly over the forecast period. It presents lucrative opportunities for key players operating in the oxygen and aerosol delivery devices market due to the enormous population base susceptible to asthma and COPD, increased public awareness of the use and benefits of these devices, affordability of medical devices, development of the R&D sector, rise in healthcare reforms, and technological advancements in aerosol delivery devices products. Furthermore, an increase in demand for inhalers and nebulizers, as well as an increase in demand for home healthcare equipment, all contribute to market expansion. Moreover, the increased focus of major manufacturers on expanding their geographical presence in rising Asia-Pacific countries in order to acquire a large portion of the oxygen and aerosol delivery devices market is likely to fuel the region's growth. APAC is also becoming a medical tourism hotspot and one of the most rapidly expanding medical operations and devices markets. APAC countries, notably India and China, have attracted medical tourists due to their developed healthcare infrastructure, affordable treatment options, and availability of highly trained clinicians.

Competitive Landscape

The key players in the Oxygen and Aerosol Delivery Devices market have shifted their focus towards bio-based components for product manufacturing and are initiating effective strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the Oxygen and Aerosol Delivery Devices market are Medline Industries, Inc., Salter Labs Inc., Vygon SA, Smiths Medical, Inc., Medicoplast International GmbH, Purple Surgical, Pennine Healthcare, Besmed Health Business Corp., Intersurgical Ltd, B. Braun Melsungen AG, ConvaTec Inc., Flexicare Medical Ltd., GaleMed Corporation, PARI GmbH, Polymedicure, Teleflex Incorporated, HSINER CO., LTD., ASID BONZ GmbH and Sumi spółka z ograniczoną.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Oxygen and Aerosol Delivery Devices Market Snapshot

Chapter 4. Global Oxygen and Aerosol Delivery Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers and Challenges

4.3. Trends

4.4. Industry Analysis – Porter’s Five Forces Analysis

4.5. Competitive Landscape & Market Share Analysis

Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis

5.1. Product Type & Market Share, 2018 & 2028

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2028 for the following Product Type:

5.2.1. Oxygen Masks

5.2.2. Nasal Cannulas/ Nasal Oxygen Catheter

5.2.3. Oxygen Connecting Tube

5.2.4. Venturi Masks

5.2.5. Non-rebreather Masks

5.2.6. Reusable Nebuliser

5.2.7. Disposable Nebuliser

5.2.8. Other Oxygen Delivery Devices

Chapter 6. Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application & Market Share, 2019 & 2026

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2028 for the following Application:

6.2.1. COPD

6.2.2. Asthma

6.2.3. Cystic Fibrosis

6.2.4. Respiratory Distress Syndrome

6.2.5. Pneumonia

6.2.6. Other Diseases

Chapter 7. Oxygen and Aerosol Delivery Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.1.2. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by Product, 2018-2028

7.1.3. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by country, 2018-2028

7.1.3.1. US

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2018-2028

7.2.2. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2018-2028

7.2.3. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, 2018-2028

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2018-2028

7.3.2. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2018-2028

7.3.3. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, 2018-2028

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application

7.4.2. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product

7.4.3. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, (US$ Million) 2018-2028

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. Middle East & Africa

7.5.1. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application

7.5.2. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product

7.5.3. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Country

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Medline Industries, Inc.

8.2.2. Salter Labs Inc.

8.2.3. Vygon SA

8.2.4. Smiths Medical, Inc.

8.2.5. Medicoplast International GmbH

8.2.6. Purple Surgical

8.2.7. Pennine Healthcare

8.2.8. Besmed Health Business Corp.

8.2.9. Intersurgical Ltd

8.2.10. B. Braun Melsungen AG

8.2.11. ConvaTec Inc.

8.2.12. Flexicare Medical Ltd.

8.2.13. GaleMed Corporation

8.2.14. PARI GmbH

8.2.15. Polymedicure

8.2.16. Teleflex Incorporated

8.2.17. HSINER CO., LTD.

8.2.18. ASID BONZ GmbH

8.2.19. Sumi spółka z ograniczoną odpowiedzialnością sp.k.

8.2.20. Other Prominent Players

Segmentation of Oxygen and Aerosol Delivery Devices Market-

By Product

  • Oxygen Masks
  • Nasal Cannulas/ Oxygen Catheter
  • Oxygen Connecting Tube
  • Venturi Masks
  • Non-rebreather Masks
  • Reusable Nebulizer
  • Disposable Nebulizer
  • Other Oxygen Delivery Devices

By Application

  • COPD
  • Asthma
  • Cystic Fibrosis
  • Respiratory Distress Syndrome
  • Pneumonia
  • Other Diseases

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Digestive Health Supplements Market?

USD 69.32 billion by 2030

CAGR of 6.8% during the forecast period.

Our Clients